Disclosed are: a 2-(5-chloropyridine-3-yl)-1-(2,5-dichlorobenzyl)-4-methyl-1H-imidazole-5-carboxylic acid crystal, which is useful as a therapeutic agent or prophylactic agent against gout, hyperuricemia, and the like; and a method for producing the same.